With over 22 years of experience in hospitals, health systems, associations, life sciences, physician practices, and suppliers, Erika is an experienced marketing strategist and supports the Quantitative Science Services offering with Go-to market planning and execution.
Erika Brooks
Marketing Director, Quantitative Science Services
相关资源
Why the Most Important Phase 3 Decisions Should Be Made Before Phase 3
博客
ICH M15 Guideline: What the Finalized Guideline Means for Model-Informed Drug Development
博客
ADC 首次人体(FIH)剂量选择:成功设计 FIH 研究的关键
博客
FAQs: The ICH M15 Guideline and What It Means for Model-Informed Drug Development
博客
Pediatric Drug Development: From “Wild West” to Model-Informed Confidence
博客
Trial Designs: Non-inferiority vs. Superiority vs. Equivalence
博客
How Model-Informed Drug Development (MIDD) Strengthens Drug Asset Valuation and Answers the Questions Investors Care About Most
博客
Delivering on Deadline: Why Pharmacometrics (PMx) Is the Anchor of Successful Regulatory Submissions
博客
